Fleming RA - Search Results

1

Relation of systemic exposure to unbound etoposide and hematologic toxicity.

Stewart CF, Arbuck SG, Fleming RA, Evans WE. Stewart CF, et al. Among authors: fleming ra. Clin Pharmacol Ther. 1991 Oct;50(4):385-93. doi: 10.1038/clpt.1991.155. Clin Pharmacol Ther. 1991. PMID: 1914374

2

Factors affecting in vitro protein binding of etoposide in humans.

Fleming RA, Evans WE, Arbuck SG, Stewart CF. Fleming RA, et al. J Pharm Sci. 1992 Mar;81(3):259-64. doi: 10.1002/jps.2600810315. J Pharm Sci. 1992. PMID: 1640365

3

Interspecies differences in in vitro etoposide plasma protein binding.

Fleming RA, Arbuck SG, Stewart CF. Fleming RA, et al. Biochem Pharmacol. 1991 Nov 6;42(11):2246-9. doi: 10.1016/0006-2952(91)90364-b. Biochem Pharmacol. 1991. PMID: 1958241 No abstract available.

4

Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.

Stewart CF, Fleming RA, Arbuck SG, Evans WE. Stewart CF, et al. Among authors: fleming ra. Cancer Res. 1990 Nov 1;50(21):6854-6. Cancer Res. 1990. PMID: 2208152

5

Changes in the clearance of total and unbound etoposide in patients with liver dysfunction.

Stewart CF, Arbuck SG, Fleming RA, Evans WE. Stewart CF, et al. Among authors: fleming ra. J Clin Oncol. 1990 Nov;8(11):1874-9. doi: 10.1200/JCO.1990.8.11.1874. J Clin Oncol. 1990. PMID: 2230875

6

Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.

Stewart CF, Fleming RA, Arkin CR, Evans WE. Stewart CF, et al. Among authors: fleming ra. Clin Pharmacol Ther. 1990 Apr;47(4):540-6. doi: 10.1038/clpt.1990.69. Clin Pharmacol Ther. 1990. PMID: 2328562

7

Etoposide: an update.

Fleming RA, Miller AA, Stewart CF. Fleming RA, et al. Clin Pharm. 1989 Apr;8(4):274-93. Clin Pharm. 1989. PMID: 2653712 Review.

8

Disposition of total and unbound etoposide following high-dose therapy.

Schwinghammer TL, Fleming RA, Rosenfeld CS, Przepiorka D, Shadduck RK, Bloom EJ, Stewart CF. Schwinghammer TL, et al. Among authors: fleming ra. Cancer Chemother Pharmacol. 1993;32(4):273-8. doi: 10.1007/BF00686172. Cancer Chemother Pharmacol. 1993. PMID: 8324869

9

Disposition of high-dose methotrexate in an obese cancer patient.

Fleming RA, Eldridge RM, Johnson CE, Stewart CF. Fleming RA, et al. Cancer. 1991 Sep 15;68(6):1247-50. doi: 10.1002/1097-0142(19910915)68:6<1247::aid-cncr2820680611>3.0.co;2-o. Cancer. 1991. PMID: 1714790

10

Aspirin alters methotrexate disposition in rheumatoid arthritis patients.

Stewart CF, Fleming RA, Germain BF, Seleznick MJ, Evans WE. Stewart CF, et al. Among authors: fleming ra. Arthritis Rheum. 1991 Dec;34(12):1514-20. doi: 10.1002/art.1780341207. Arthritis Rheum. 1991. PMID: 1747136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters